Hosted on MSN7h
For Your Patients: What Is Multiple Myeloma?
Although the cause of multiple myeloma is not known, research shows that genetic changes in the DNA of a single plasma cell ...
emjreviews.com10h
High-Risk Genetic Markers Predict Poor Outcomes in Multiple Myeloma
Study reveals multiple high-risk genetic changes predict worse multiple myeloma outcomes across all treatments.
Medpage Today on MSN16h
The Basics of Multiple Myeloma
In spite of recent advances in the management of multiple myeloma, cure has been elusive, with efforts to improve long-term ...
Targeted Oncology9d
Gasparetto Explains Rationale for Quadruplet Front Line in Transplant-Ineligible Myeloma
In a Community Case Forum in partnership with the North Carolina Oncology Association, Cristina Gasparetto, MD, discussed the ...
Medscape24d
Familial Predisposition to Monoclonal Gammopathy of Unknown Significance, Waldenström's Macroglobulinemia, and Multiple Myeloma
An Icelandic family with multiple cases of MGUS, WM, and lymphoma was first described in 1978. In vitro testing of peripheral blood lymphocytes revealed increased production of immunoglobulins in ...
The New England Journal of Medicine19d
CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma
A 54-year-old woman with IgG kappa multiple myeloma (diagnosed in November 2019) and a high-risk cytogenetic profile (t[4;14] and gain[1q]) had received frontline therapy with bortezomib ...
Nature1mon
IgE levels correlate with survival in patients with multiple myeloma
Serum levels of polyclonal IgG, IgA and IgM are usually decreased in patients with multiple myeloma (MM); however, little is known about the prognostic significance of polyclonal levels of IgE in ...